Eesti - eesti - Ravimiamet

menarini international operations luxembourg s.a. - olmesartaanmedoksomiil+amlodipiin - õhukese polümeerikattega tablett - 20mg+5mg 300tk; 20mg+5mg 14tk; 20mg+5mg 30tk; 20mg+5mg 56tk; 20mg+5mg 28tk; 20mg+5mg 98tk; 20mg+5mg 280tk; 20mg+5mg 90tk

Eesti - eesti - Ravimiamet

menarini international operations luxembourg s.a. - olmesartaanmedoksomiil+amlodipiin - õhukese polümeerikattega tablett - 40mg+5mg 10tk; 40mg+5mg 98tk; 40mg+5mg 300tk; 40mg+5mg 14tk; 40mg+5mg 50tk; 40mg+5mg 28tk

Eesti - eesti - Ravimiamet

menarini international operations luxembourg s.a. - olmesartaanmedoksomiil+amlodipiin - õhukese polümeerikattega tablett - 40mg+10mg 14tk; 40mg+10mg 56tk; 40mg+10mg 280tk; 40mg+10mg 50tk; 40mg+10mg 30tk; 40mg+10mg 90tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

biogen netherlands b.v. - dimetüülfumaraat - hulgiskleroos - immunosupressandid - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Euroopa Liit - eesti - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - sclerosis multiplex, relapsing-remitting - immunosupressandid - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Euroopa Liit - eesti - EMA (European Medicines Agency)

mylan ireland limited - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Euroopa Liit - eesti - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Euroopa Liit - eesti - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 56tk